Agree with all of that regarding realistic expectations for a biotech investment, Ph2 etc…but then you have the “one year play” comment and suggestions over the past year or so that some type of commercial success/progress/deal will come sooner than we expect. We need to exercise patience of course but it could be said that there is some mixed messaging floating around and when added to the scope of various platforms and possibilities, it can be hard to grasp what the upcoming path/direction is. Just my 2c.
Why IMU is a multi multi bagger, page-20713
-
- There are more pages in this discussion • 5,220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
